Get App Open
In App
Lending
Lending
Open App
you are here:

Aurobindo Pharma Ltd.

BSE: 524804 | NSE: AUROPHARMA |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE406A01037 | SECTOR: Pharmaceuticals & Drugs

BSE Live

Sep 19, 12:02
1124.00 -4.50 (-0.40%)
Volume
AVERAGE VOLUME
5-Day
34,886
10-Day
64,785
30-Day
88,946
14,886
  • Prev. Close

    1128.50

  • Open Price

    1131.90

  • Bid Price (Qty.)

    1122.40 (81)

  • Offer Price (Qty.)

    1123.75 (18)

NSE Live

Sep 19, 12:02
1123.10 -5.80 (-0.51%)
Volume
AVERAGE VOLUME
5-Day
1,202,802
10-Day
1,573,938
30-Day
1,410,381
484,703
  • Prev. Close

    1128.90

  • Open Price

    1130.00

  • Bid Price (Qty.)

    1123.10 (28)

  • Offer Price (Qty.)

    1123.40 (24)

Financials

Cash Flow of Aurobindo Pharma (in Rs. Cr.) Mar 20 Mar 19 Mar 18 Mar 17 Mar 16  
  12 mths 12 mths 12 mths 12 mths 12 mths  
Net Profit/Loss Before Extraordinary Items And Tax 2,377.70 1,964.62 2,342.94 2,178.57 2,147.84  
Net CashFlow From Operating Activities 2,161.73 529.89 922.40 2,457.20 1,185.18  
Net Cash Used In Investing Activities -921.57 -1,297.36 -990.60 -1,542.05 -1,390.11  
Net Cash Used From Financing Activities -1,252.39 599.40 439.69 -1,328.99 514.97  
Foreign Exchange Gains / Losses 2.97 -3.18 0.00 0.00 0.00  
Adjustments On Amalgamation Merger Demerger Others 0.00 0.00 0.00 0.00 0.00  
Net Inc/Dec In Cash And Cash Equivalents -9.26 -171.25 371.49 -413.84 310.04  
Cash And Cash Equivalents Begin of Year 68.70 239.95 -131.54 283.90 -26.14  
Cash And Cash Equivalents End Of Year 59.44 68.70 239.95 -129.94 283.90  
Source : Dion Global Solutions Limited

Results of Aurobindo Pharm